Maryland 2025 Regular Session

Maryland House Bill HB1087

Introduced
2/5/25  
Refer
2/5/25  
Report Pass
3/15/25  
Engrossed
3/17/25  
Refer
3/17/25  
Report Pass
3/27/25  
Enrolled
4/2/25  
Chaptered
5/20/25  

Caption

Health Insurance - Step Therapy or Fail-First Protocols - Drugs to Treat Associated Conditions of Advanced Metastatic Cancer

Companion Bills

MD SB921

Crossfiled Health Insurance - Step Therapy or Fail-First Protocols - Drugs to Treat Associated Conditions of Advanced Metastatic Cancer

Previously Filed As

MD SB515

Health Insurance – Step Therapy or Fail–First Protocol – Revisions

MD HB785

Health Insurance - Step Therapy or Fail-First Protocol and Prior Authorization - Revisions

MD SB990

Maryland Medical Assistance Program and Health Insurance - Step Therapy, Fail-First Protocols, and Prior Authorization - Prescription Drugs to Treat Serious Mental Illness

MD HB1423

Maryland Medical Assistance Program and Health Insurance - Step Therapy, Fail-First Protocols, and Prior Authorization - Prescription Drugs to Treat Serious Mental Illness

MD SB791

Health Insurance - Utilization Review - Revisions

MD HB305

Health Insurance - Utilization Review - Revisions

MD HB932

Health Insurance - Utilization Review - Revisions

MD SB308

Health Insurance – Utilization Review – Revisions

MD HB876

Health Insurance - Pharmacy Benefits Managers - Specialty Drugs

MD SB75

Insurance and Maryland Medical Assistance Program – Treatment of Alopecia Areata – Coverage Requirements

Similar Bills

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA AB852

Health care practitioners: electronic prescriptions.

CA AB149

Controlled substances: prescriptions.

TX HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.